Effect of gold on survival of tumor-bearing mice

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 5, 1998, Pages 403-406

  Kamei, Hideo ^a   Koide, Tatsurou ^a   Kojima, Takashi ^b   Hashimoto, Yoko ^a   Hasegawa, Makoto ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antitumor; Cisplatinum; Gold

Indexed keywords

AUROTHIOMALATE; CISPLATIN; GOLD;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LD 50; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; SURVIVAL TIME; TUMOR CELL;

EID: 0032424027     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.403     Document Type: Article

References (13)

1. Bendix G and Bjelle A. A 10-year follow-up of parenteral gold therapy in patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:169-176.
2. Galinfo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A, et al. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. J Rheumatol 1997;24:633-638.
3. Fiocco U, Cozzi L, Rubaltelli, et al. Long-term follow-up of rheumatoid and psoriatic proliferative knee joint synovitis. Br J Rheumatol 1996;35:155-163.
4. Koide T, Kojima T, and Kamei H. Antitumor effect of gold as revealed by growth suppression of cultured cells. Cancer Biother & Radiopharm 1998;13(3):189-192.
5. Mirabelli CK, Johnson RK, Faucette LF, et al. Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold coordination complexes. J Med Chem 1986; 29:218-223.
6. Snyder RM, Mirabelli CK, Johnson RK, et al. Modulation of the antitumor and biochemical properties of bis (diphenylphosphine) ethane with metals. Cancer Res 1986; 46:5054-5-60.
7. Haiduc I and Silvestru C. Rhodium, iridium, copper and gold antitumor arganometallic compounds. In Vivo 1989; 3:289-293.
8. Pandya KJ, Chang AY, Qazi R, et al. Combination chemotherapy for advanced colorectal cancer. A pilot study. Am J Clin Oncol 1986;9:31-34.
9. Fucks JZ, Aisner J, Van Echo DA, et al. Randomized study of cyclophosphamide, doxorubicin and etoposide (VIP-213) with or without cisplatinum in non-small cell lung cancer. J Clin Oncol 1983;1:295-301.
10. Lachini ML, Lopes AG, Malnic G, et al. Cisplatinum-induced lesion of proximal tubule acidification in the rate. Re Physiol Biochem 1992;15:1-6-112.
11. Tomioka R and King TE Jr. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997;155:101-1020.
12. Snowden N, Dietch DM, The LS, et al. Antibody deficiency associated with gold treatment: natural history and management in 22 patients. Ann Rheum Dis 1996;55:616-621.
13. Cheriathundam E and Alvares AP. Specific differences in the renal toxicity of the antiarthritic drug, gold sodium thiomalate. J Biochem Toxicol 1996;11:175-181.